Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by HOP S. TRAN CAO and CHING-WEI DAVID TZENG.
HOP S. TRAN CAO
Connection Strength
6.592
CHING-WEI DAVID TZENG
  1. Impact of Non-Hepatectomy Opioid Reduction Efforts on Post-Hepatectomy Opioid Prescriptions: Analysis of 2,005 Patients. J Am Coll Surg. 2025 Jan 14.
    View in: PubMed
    Score: 0.250
  2. CEA Rebound After Discontinuation of Pre-Hepatectomy Chemotherapy Predicts Worse Outcomes After Resection of Colorectal Cancer Liver Metastases. Ann Surg Oncol. 2024 Nov 08.
    View in: PubMed
    Score: 0.246
  3. Robotic Hepatic Parenchymal Transection Techniques: A Choice Between Imperfect Tools. Ann Surg Oncol. 2025 Jan; 32(1):438-439.
    View in: PubMed
    Score: 0.245
  4. A propensity score matched cost analysis of robotic versus open hepatectomy. HPB (Oxford). 2024 Nov; 26(11):1379-1386.
    View in: PubMed
    Score: 0.242
  5. Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features. Oncologist. 2024 Jun 03; 29(6):e803-e810.
    View in: PubMed
    Score: 0.239
  6. Exceptional pathologic response to preoperative therapy in the context of mutational profiling for colorectal liver metastases. J Gastrointest Surg. 2024 Jul; 28(7):1181-1184.
    View in: PubMed
    Score: 0.238
  7. Utilizing risk-stratified pathways to personalize post-hepatectomy discharge planning: A contemporary analysis of 1,354 patients. Am J Surg. 2024 Jul; 233:17-23.
    View in: PubMed
    Score: 0.232
  8. A Practical Guide to Inflow Control, Retraction, and Exposure for Robotic Hepatectomy. Ann Surg Oncol. 2024 Mar; 31(3):1833.
    View in: PubMed
    Score: 0.230
  9. Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma. Ann Surg Oncol. 2023 Nov; 30(12):7309-7318.
    View in: PubMed
    Score: 0.227
  10. Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion. HPB (Oxford). 2023 07; 25(7):758-765.
    View in: PubMed
    Score: 0.219
  11. Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - does pathologic response mean better outcomes? HPB (Oxford). 2023 04; 25(4):472-480.
    View in: PubMed
    Score: 0.218
  12. Individual components of post-hepatectomy care pathways have differential impacts on length of stay. Am J Surg. 2023 01; 225(1):53-57.
    View in: PubMed
    Score: 0.213
  13. Robotic Extended Right Hepatectomy for Colorectal Liver Metastasis. Ann Surg Oncol. 2022 Dec; 29(13):8455.
    View in: PubMed
    Score: 0.212
  14. Opioid Discharge Prescriptions After Inpatient Surgery: Risks of Rebound Refills by Length of Stay. J Surg Res. 2022 10; 278:111-118.
    View in: PubMed
    Score: 0.208
  15. Lymphadenectomy and margin-negative resection for biliary tract cancer surgery in the United States-Differential technical performance by approach. J Surg Oncol. 2022 Sep; 126(4):658-666.
    View in: PubMed
    Score: 0.207
  16. Prospective Implementation of Standardized Post-Hepatectomy Care Pathways to Reduce Opioid Prescription Volume after Inpatient Surgery. J Am Coll Surg. 2022 07 01; 235(1):41-48.
    View in: PubMed
    Score: 0.206
  17. Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection. Ann Surg Oncol. 2022 Aug; 29(8):5156-5164.
    View in: PubMed
    Score: 0.206
  18. Robotic Completion Radical Cholecystectomy with Fluorescence Guidance. Ann Surg Oncol. 2021 Oct; 28(11):6834.
    View in: PubMed
    Score: 0.192
  19. Time to Rethink Upfront Surgery for Resectable Intrahepatic Cholangiocarcinoma? Implications from the Neoadjuvant Experience. Ann Surg Oncol. 2021 Oct; 28(11):6725-6735.
    View in: PubMed
    Score: 0.190
  20. Surgical Management of Localized Hepatocellular Carcinoma in Times of Crisis: A Strategic Approach to Resource Utilization. J Hepatocell Carcinoma. 2020; 7:155-158.
    View in: PubMed
    Score: 0.185
  21. Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg. 2020 08; 272(2):e106-e111.
    View in: PubMed
    Score: 0.183
  22. Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. Surg Oncol. 2020 Sep; 34:182-185.
    View in: PubMed
    Score: 0.180
  23. Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. J Gastrointest Surg. 2014 Jan; 18(1):16-24; discussion 24-5.
    View in: PubMed
    Score: 0.115
  24. Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer. Clin Cancer Res. 2025 Jan 17; 31(2):387-402.
    View in: PubMed
    Score: 0.062
  25. Propensity Score-Matched Analysis of Liver Venous Deprivation and Portal Vein Embolization Before Planned Hepatectomy in Patients with Extensive Colorectal Liver Metastases and High-Risk Factors for Inadequate Regeneration. Ann Surg Oncol. 2024 Dec 04.
    View in: PubMed
    Score: 0.062
  26. Escalated-dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States. Cancer Med. 2024 Jun; 13(12):e7434.
    View in: PubMed
    Score: 0.060
  27. Reproducibility and efficiency of liver volumetry using manual method and liver analysis software. HPB (Oxford). 2024 07; 26(7):911-918.
    View in: PubMed
    Score: 0.059
  28. Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress? Ann Surg Oncol. 2024 May; 31(5):3062-3068.
    View in: PubMed
    Score: 0.058
  29. Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2024 Apr; 31(4):2547-2556.
    View in: PubMed
    Score: 0.058
  30. Laparoscopic transverse abdominis plane block: how I do it and a cost efficiency analysis. Langenbecks Arch Surg. 2023 Dec 26; 409(1):16.
    View in: PubMed
    Score: 0.058
  31. Correction: Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. 2023 Sep; 30(9):5405.
    View in: PubMed
    Score: 0.057
  32. Incidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver Metastases. J Gastrointest Surg. 2023 11; 27(11):2388-2395.
    View in: PubMed
    Score: 0.056
  33. ASO Author Reflections: The Patient First Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. 2023 09; 30(9):5401-5402.
    View in: PubMed
    Score: 0.056
  34. Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. 2023 Sep; 30(9):5390-5400.
    View in: PubMed
    Score: 0.056
  35. Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study. Ann Surg Oncol. 2023 Aug; 30(8):4904-4911.
    View in: PubMed
    Score: 0.055
  36. Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis. Oncologist. 2023 04 06; 28(4):327-332.
    View in: PubMed
    Score: 0.055
  37. Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases. Liver Cancer. 2023 Aug; 12(3):198-208.
    View in: PubMed
    Score: 0.055
  38. Impact of cumulative operative time on postoperative complication risk in simultaneous resections of colorectal liver metastases and primary tumors. HPB (Oxford). 2023 03; 25(3):347-352.
    View in: PubMed
    Score: 0.054
  39. Technique for Robotic Pancreaticojejunostomy. J Am Coll Surg. 2023 05 01; 236(5):e12-e14.
    View in: PubMed
    Score: 0.054
  40. Bintrafusp alfa, an anti-PD-L1:TGF-? trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer. Cancer Res Commun. 2022 09; 2(9):979-986.
    View in: PubMed
    Score: 0.053
  41. Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. J Hepatobiliary Pancreat Sci. 2023 Jan; 30(1):e1-e2.
    View in: PubMed
    Score: 0.053
  42. Comparative analysis of opioid use between robotic and open pancreatoduodenectomy. J Hepatobiliary Pancreat Sci. 2023 Apr; 30(4):523-531.
    View in: PubMed
    Score: 0.052
  43. Risk-stratified posthepatectomy pathways based upon the Kawaguchi-Gayet complexity classification and impact on length of stay. Surg Open Sci. 2022 Jul; 9:109-116.
    View in: PubMed
    Score: 0.052
  44. Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States. Cancer. 2022 07 01; 128(13):2529-2539.
    View in: PubMed
    Score: 0.052
  45. Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma. J Pers Med. 2021 Dec 01; 11(12).
    View in: PubMed
    Score: 0.050
  46. Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases. J Gastrointest Surg. 2022 04; 26(4):791-801.
    View in: PubMed
    Score: 0.050
  47. Early Experience of a Robotic Foregut Surgery Program at a Cancer Center: Video of Shared Steps in Robotic Pancreatoduodenectomy and Gastrectomy. Ann Surg Oncol. 2022 Jan; 29(1):285.
    View in: PubMed
    Score: 0.050
  48. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status. Br J Surg. 2021 08 19; 108(8):968-975.
    View in: PubMed
    Score: 0.049
  49. Fast-track two-stage hepatectomy by concurrent portal vein embolization at first-stage hepatectomy in hybrid interventional radiology / operating suite. Surg Oncol. 2021 Dec; 39:101648.
    View in: PubMed
    Score: 0.049
  50. Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal?Cancer. J Am Coll Surg. 2021 08; 233(2):272-284.e13.
    View in: PubMed
    Score: 0.049
  51. Preliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver Metastases. J Am Coll Surg. 2021 07; 233(1):82-89.e1.
    View in: PubMed
    Score: 0.048
  52. Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes. Surg Oncol. 2021 Mar; 36:138-146.
    View in: PubMed
    Score: 0.047
  53. Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases. J Gastrointest Surg. 2021 01; 25(1):186-194.
    View in: PubMed
    Score: 0.047
  54. External Retraction Technique for Robotic Pancreatoduodenectomy. J Am Coll Surg. 2020 11; 231(5):e8-e10.
    View in: PubMed
    Score: 0.046
  55. COVID-19 outbreak and surgeonsresponse at a Cancer Center in the United States. Glob Health Med. 2020 Apr 30; 2(2):135-137.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.